Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

AdvanDx Receives FDA 510(k) Clearance for 90 Minutes Protocol for Yeast Traffic Light® PNA FISH®

July 29, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

WOBURN, Mass.and VEDBAEK, Denmark , July 29 /- AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its Yeast Traffic Light® PNA FISH® test.  The faster protocol reduces the PNA FISH turn-around time from the original 2.5...

TOPICS:

BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer

July 29, 2010 4:33 am | by Becton, Dickinson and Company | News | Comments

(July 28, 2010) -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the promotion of Vincent A. Forlenza, President, who assumes the title of Chief Operating Officer in addition to his current title. Mr. Forlenza

TOPICS:

Integra LifeSciences 2Q profit rises 35 percent

July 29, 2010 3:45 am | by The Associated Press | News | Comments

Medical device maker Integra LifeSciences Holdings Corp. said Thursday its profit grew 35 percent in the second quarter as product sales increased, and the company took fewer charges.The company said its profit rose to $15.2 million, or 50 cents per share, from $11.2 million, or 38 cents per...

Advertisement

New lab test could identify imatinib resistance

July 28, 2010 10:35 pm | by EurekAlert | News | Comments

(American Association for Cancer Research) Scientists in Japan may have developed a way to accurately predict those patients who will resist treatment with imatinib, which is the standard of care for chronic myeloid leukemia.

TOPICS:

Glucose Monitors Get Under the Skin

July 28, 2010 8:34 pm | by Massachusetts Institute of Technology | News | Comments

Implantable devices work in diabetic pigs for over a year--human tests could be next.

TOPICS:

Bruker 2Q profit rises 75 pct on higher revenue

July 28, 2010 2:45 pm | by The Associated Press | News | Comments

Shares of Bruker Corp. rose Wednesday after the maker of scientific instruments reported a 75 percent increase in second-quarter profits as revenue climbed.The company earned $22.6 million, or 14 cents per share, compared with $12.9 million, or 8 cents per share, in the same period a year...

Best hope for saving Arctic sea ice is cutting soot emissions, says Stanford researcher

July 28, 2010 2:43 pm | by EurekAlert | News | Comments

(Stanford University) Soot from the burning of fossil fuels and solid biofuels contributes far more to global warming than has been thought, according to a new Stanford study. But, unlike carbon dioxide, soot lingers only a few weeks in the atmosphere, so cutting emissions could...

TOPICS:

Huntington's disease discovery provides new hope for treatment

July 28, 2010 2:43 pm | by EurekAlert | News | Comments

(University of Melbourne) Australian scientists have identified the behavior of the mutant protein "huntingtin" which leads to the fatal Huntington's disease providing potential targets to treat the disease, a University of Melbourne study reveals.

TOPICS:
Advertisement

Current list of MAK and BAT values presented with 61 modifications and new entries

July 28, 2010 2:43 pm | by EurekAlert | News | Comments

(Deutsche Forschungsgemeinschaft) The Deutsche Forschungsgemeinschaft Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has presented the 2010 list of MAK and BAT values containing new data on 61 substances. These values for the...

TOPICS:

Express Scripts 2Q net income rises 50 percent

July 28, 2010 1:45 pm | by The Associated Press | News | Comments

Pharmacy-benefits manager Express Scripts Inc. said Wednesday its second-quarter profit rose 50 percent as revenue soared from new business generated by its NextRx unit.In April 2009, the company bought WellPoint's pharmacy benefit management business NextRx for about $4.68 billion. Pharmacy...

Waters Corp. 2Q profit rises 21 percent

July 28, 2010 1:45 pm | by The Associated Press | News | Comments

Waters Corp., a maker of scientific instruments, on Wednesday said second-quarter profit increased by 21 percent as revenue rose, partly on demand for new products.The company earned $84.9 million, or 90 cents per share, compared with $69.9 million, or 72 cents per share, in the same period a...

Spectranetics posts profit in 2Q

July 28, 2010 1:45 pm | by The Associated Press | News | Comments

Medical device maker Spectranetics Corp.. turned in a profit in the second quarter as operating expenses dipped.Spectranetics recorded net income of $91,000, or no cents per share, in the quarter ended June 30. That compares with a loss of $2.3 million, or 7 cents per share, during the same...

FDA CONSUMER HEALTH INFORMATION - Combating Misuse and Abuse of Prescription Drugs: Q & A with Michael Klein, Ph.D.

July 28, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md. , July 28 /PRNewswire-USNewswire/ -- Dr. Michael Klein , director of the Food and Drug Administration (FDA) Controlled Substance Staff, discusses how FDA works with other entities to confront and to prevent misuse and abuse of prescription drugs.   (Logo:...

TOPICS:

New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government

July 28, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON , July 28 /PRNewswire-USNewswire/ -- In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements , Joy Sturm , Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how...

TOPICS:

U.S. Court of Appeals Rules on Validity of Lilly's Gemzar Method-of-Use Patent

July 28, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS , July 28 /- Eli Lilly and Company (NYSE: LLY ) today announced that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling by the U.S. District Court for the Eastern District of Michigan that Gemzar's method-of-use patent is invalid. "We strongly...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading